Manuscripts
Showing 1572 manuscripts.
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
Citation
Robert Shafer, Michael J. Kozal, Mark A. Winters, Astrid K.N. Iversen, David Katzenstein, Margaret V. Ragni, William A. Meyer, Phalguni Gupta, Suraiya Rasheed, Robert W. Coombs, Michael Katzman, Susan A. Fiscus, Thomas C. Merigan. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. Journal of Infectious Diseases. 1994. 169: 722-9.Year
1994
Journal
Journal of Infectious Diseases
Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitis
Citation
Mark A. Jacobson, Bruce Polsky, Dennis M. Causey, Roger Davis, William P. Tong, James O'Donnell, Baruch D. Kuppermann, Murk-Hein Heinemann, Judith Feinberg, Patricia S. Lizak, John G. Gambertoglio, Francesca Aweeka. Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitis. Antimicrobial Agents and Chemotherapy. 1994. 38: 1190-3.Year
1994
Journal
Antimicrobial Agents and Chemotherapy
Prototypical HTLV-I/II infection is rare in LGL leukemia
Citation
T. Loughran, Michael P. Sherman, Frank Ruscetti, Sharon E. Frey, Tom Coyle, Richard Montagna, Barbara Jones, Gordon Starkebaum, Bernard Poiesz. Prototypical HTLV-I/II infection is rare in LGL leukemia. Leukemia Research. 1994. 18: 423-9.Year
1994
Journal
Leukemia Research
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment: Results of AIDS Clinical Trials Group Protocol 076
Citation
Edward M. Connor, Rhoda S. Sperling, Richard D. Gelber, P. Kiselev, Gwendolyn B. Scott, Mary Jo O'Sullivan, Russell B. Van Dyke, Mohammed Bey, William T. Shearer, R. L. Jacobson. Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment: Results of AIDS Clinical Trials Group Protocol 076. New England Journal of Medicine. 1994. 331: 1173-80.Year
1994
Journal
New England Journal of Medicine
The Role of Obstetric Interventions in the Prevention of Pediatric Human Immunodeficiency Virus Infection
Citation
Howard Minkoff. The Role of Obstetric Interventions in the Prevention of Pediatric Human Immunodeficiency Virus Infection. American Journal of Obstetrics and Gynecology. 1994. 171: 1167-1175.Year
1994
Journal
American Journal of Obstetrics and Gynecology
Treatment of HIV Infection in Infancy
Citation
Edward M. Connor. Treatment of HIV Infection in Infancy. Clinics in Perinatology. 1994. 21: 163-177.Year
1994
Journal
Clinics in Perinatology
Pivaloyloxymethyl esters of acyclic nucleoside phosphonates
Citation
Ranga V. Srinivas, Brian Robbins, Michael Connolly, Y. Gong, N. Bischofberger, Arnold Fridland. Pivaloyloxymethyl esters of acyclic nucleoside phosphonates. International Antiviral News. 1994. 2: 53-55.Year
1994
Journal
International Antiviral News
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS
Citation
Michael N. Dohn, Winkler Weinberg, Ramon A. Torres, Stephen E. Follansbee, P. Caldwell, Joseph Scott, Joseph Gathe, D. P. Haghighat, James H. Sampson, Jared M. Spotkov, Stanley C. Deresinski, Richard D. Meyer, Danny Lancaster. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Annals of Internal Medicine. 1994. 121: 174-80.Year
1994
Journal
Annals of Internal Medicine
Maternal and Pediatric AIDS in the United States: the Current Situation and Future Research Directions
Citation
A. Blank. Maternal and Pediatric AIDS in the United States: the Current Situation and Future Research Directions. ACTA Paediatrica. 1994. s400: 106-110.Year
1994
Journal
ACTA Paediatrica
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3
Citation
Margaret A. Fischl, Lionel Resnick, Robert W. Coombs, A. B. Kremer, John C. Pottage, Robert J. Fass, Kenneth H. Fife, William G. Powderly, Ann C. Collier, Richard L. Aspinall. The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3. Journal of Acquired Immune Deficiency Syndromes. 1994. 7: 139-47.Year
1994
Journal
Journal of Acquired Immune Deficiency Syndromes